Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Human Identification Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global human identification market reached a value of US$ 1.54 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 3.28 Billion by 2027, exhibiting a CAGR of 13.43% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Human identification refers to a technique used to analyze the deoxyribonucleic acid (DNA) sample for the identification of individuals and forensic investigation. It consists of body part detectors that assist in detecting lips, face, heads, shoulders, fingerprints, and palms.
It also utilizes next-generation sequencing (NGS), capillary electrophoresis, rapid DNA analysis, polymerase chain reaction (PCR), nucleic acid purification, and extraction technologies. Human identification is widely used for criminal identification, overall analytics of human traits, identifying missing persons, casualties of war, disaster victims, and cause and manner of death. It also assists in tracking individual criminal record, identifying traces, and pardoning decisions.
Human Identification Market Trends:
The increasing demand for DNA analysis on account of rising criminal rates across the globe is one of the key factors driving the growth of the market. In line with this, human identification is widely used in forensics, disaster victim identification, and anthropology for eliminating wrongly associated individuals and redirecting resources to more viable avenues of investigation.
Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML), that assists in mapping and recording facial features, obtaining high-quality source samples, and improving system efficiency, are providing an impetus to the market growth.
Additionally, recent developments in sequencing technology have enhanced the utilization of capillary electrophoresis (CE) and massively parallel sequencing (MPS) methods for human identification in forensic and paternity testing labs, which, in turn, is positively impacting the market growth. Apart from this, extensive research and development (R&D) activities and the implementation of various government policies to provide funding for forensic programs are creating a positive outlook for the market.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Eurofins Scientific, Hamilton Company, Illumina Inc., Laboratory Corporation of America Holdings, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Siemens AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global human identification market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global human identification market?
- What are the key regional markets?
- What is the breakup of the market based on the product & service?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global human identification market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Human Identification Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product & Service
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Assay Kits and Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Technology
7.1 Polymerase Chain Reaction (PCR)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Next Generation Sequencing (NGS)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Nucleic Acid Purification and Extraction
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Capillary Electrophoresis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Rapid DNA Analysis
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Forensic Applications
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Paternity Testing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Forensic Laboratories
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Centers, Academic and Government Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bio-Rad Laboratories Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Eurofins Scientific
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Hamilton Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Illumina Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Laboratory Corporation of America Holdings
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 PerkinElmer Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Promega Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Qiagen N.V.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Siemens AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/j03qt
Attachment
